Timberlyne Therapeutics Funding & Investors
San Diego, CA
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs.
timberlyne-tx.comTotal Amount Raised: $180,000,000
Timberlyne Therapeutics Funding Rounds
Series A
$180,000,000
Series A Investors
AbingworthBain Capital Life SciencesVenrock Healthcare Capital Partners3H Health InvestmentLilly Asia VenturesBraidwellBoyu Capital
Funding info provided by Diffbot.